Cargando…

Retroperitoneal lymph node dissection for germ cell tumour

Retroperitoneal lymph node dissection (RPLND) is an infrequently used, but important part of the management of men with metastatic germ cell tumours. The surgery aims to remove the lymph nodes from the primary retroperitoneal landing site from testicular tumours, usually accomplished by removing tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Vy, Gibson, Luke, Sengupta, Shomik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807376/
https://www.ncbi.nlm.nih.gov/pubmed/33457283
http://dx.doi.org/10.21037/tau-2019-suc-18
_version_ 1783636730324189184
author Tran, Vy
Gibson, Luke
Sengupta, Shomik
author_facet Tran, Vy
Gibson, Luke
Sengupta, Shomik
author_sort Tran, Vy
collection PubMed
description Retroperitoneal lymph node dissection (RPLND) is an infrequently used, but important part of the management of men with metastatic germ cell tumours. The surgery aims to remove the lymph nodes from the primary retroperitoneal landing site from testicular tumours, usually accomplished by removing tissue surrounding the great vessels using a split-and-roll technique. RPLND may be carried out as a primary surgical procedure for staging or treatment of metastases. More frequently it is undertaken as a follow-up after chemotherapy for a residual mass that may contain viable tumour or teratoma. RPLND is recognised as a major surgery with significant risks of morbidity and complications, particularly loss of ejaculation secondary to damage to hypogastric nerves. In select cases, especially during primary RPLND, nerve-sparing surgery may help preserve ejaculation, which maybe of importance to the young men usually treated for germ cell tumours. In recent years, the development of minimally invasive approaches have also offered a means for potential improvement in the pain and post-operative recovery from RPLND. We conducted a narrative review of the literature to assess indications for RPLND, along with operative approaches and techniques and related outcomes. The majority of available literature is in the form of relatively small retrospective case series, hence additional research in this area is desirable.
format Online
Article
Text
id pubmed-7807376
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-78073762021-01-15 Retroperitoneal lymph node dissection for germ cell tumour Tran, Vy Gibson, Luke Sengupta, Shomik Transl Androl Urol Review Article on Surgery for Urologic Cancers Retroperitoneal lymph node dissection (RPLND) is an infrequently used, but important part of the management of men with metastatic germ cell tumours. The surgery aims to remove the lymph nodes from the primary retroperitoneal landing site from testicular tumours, usually accomplished by removing tissue surrounding the great vessels using a split-and-roll technique. RPLND may be carried out as a primary surgical procedure for staging or treatment of metastases. More frequently it is undertaken as a follow-up after chemotherapy for a residual mass that may contain viable tumour or teratoma. RPLND is recognised as a major surgery with significant risks of morbidity and complications, particularly loss of ejaculation secondary to damage to hypogastric nerves. In select cases, especially during primary RPLND, nerve-sparing surgery may help preserve ejaculation, which maybe of importance to the young men usually treated for germ cell tumours. In recent years, the development of minimally invasive approaches have also offered a means for potential improvement in the pain and post-operative recovery from RPLND. We conducted a narrative review of the literature to assess indications for RPLND, along with operative approaches and techniques and related outcomes. The majority of available literature is in the form of relatively small retrospective case series, hence additional research in this area is desirable. AME Publishing Company 2020-12 /pmc/articles/PMC7807376/ /pubmed/33457283 http://dx.doi.org/10.21037/tau-2019-suc-18 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article on Surgery for Urologic Cancers
Tran, Vy
Gibson, Luke
Sengupta, Shomik
Retroperitoneal lymph node dissection for germ cell tumour
title Retroperitoneal lymph node dissection for germ cell tumour
title_full Retroperitoneal lymph node dissection for germ cell tumour
title_fullStr Retroperitoneal lymph node dissection for germ cell tumour
title_full_unstemmed Retroperitoneal lymph node dissection for germ cell tumour
title_short Retroperitoneal lymph node dissection for germ cell tumour
title_sort retroperitoneal lymph node dissection for germ cell tumour
topic Review Article on Surgery for Urologic Cancers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807376/
https://www.ncbi.nlm.nih.gov/pubmed/33457283
http://dx.doi.org/10.21037/tau-2019-suc-18
work_keys_str_mv AT tranvy retroperitoneallymphnodedissectionforgermcelltumour
AT gibsonluke retroperitoneallymphnodedissectionforgermcelltumour
AT senguptashomik retroperitoneallymphnodedissectionforgermcelltumour